Skip to main content

Table 1 Initial demographic parameters of the patients in the intention-to-treat population

From: Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study

 

Placebo (n = 87)

Pentoxifylline (n = 87)

P-value

Age (years)

63.8 ± 9.4

63.7 ± 10.1

0.972

Sex (M/F)

56/31

47/40

0.217

Duration of diabetes (years)

12.6 ± 8.1

12.4 ± 8.3

0.917

BMI (kg/m2)

25.4 ± 3.5

26.0 ± 3.1

0.259

Systolic BP (mmHg)

127.8 ± 11.9

127.6 ± 14.1

0.938

Diastolic BP (mmHg)

74.0 ± 8.9

76.2 ± 10.4

0.141

Statin treatment (%)

56.3

50.0

0.448

Diabetes medication

   

 Sulfonylurea (%)

59.8

62.8

0.755

 Metformin (%)

83.9

86.0

0.832

 Thiazolidinedione (%)

5.7

7.0

0.766

 DPP-4 inhibitor (%)

25.3

25.6

1.000

 Insulin (%)

13.8

16.3

0.676

  1. Data are presented as means ± standard deviation (SD), or numbers (percentage)
  2. BMI body mass index, BP blood pressure, DPP-4 dipeptidyl peptidase 4
  3. The independent t-test was used to compare continuous variables between the groups. The χ2 test was implemented for categorical data
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us